Dandelion Root to Treat Cancer - Quick Reference Sheet
evipedia.ai
← Back

Dandelion Root to Treat Cancer

Created on 08/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A cheap, food-grade herb with a long record as a digestive bitter. Its cancer claim rests entirely on laboratory dishes and mice; nothing comparable has been shown in a person, and no cancer trial of the root is registered anywhere today. The largest documented harm is not the plant but the standard treatment people drop while taking it. (Full Review)

Protocol

Traditional decoction
3–5 g root, 2–3× daily
Simmered in 150 mL water for 10–15 minutes. Commission E: 3–4 g twice daily.
Capsule form
500–520 mg, 1–3 capsules daily
Approximates the traditional dose. Tincture 1:5 in 30% alcohol, 5–10 mL daily.
Integrative add-on approach
Alongside conventional treatment
Dosing paused around chemotherapy cycles. Replacement use carries the mortality signal.
Time to effect
Cancer indication
None to state
No human endpoint has been shown to change at any duration.
Digestive effects
Within hours
Appetite and post-meal comfort would shift within days if the bitter action is doing anything.
Diuretic effects
Within hours
Increased urine flow from the first dose.

Benefits

Contraindications
  • Bile-duct obstruction of any cause, or acute cholecystitis
  • Symptomatic gallstones, unless supervised by a physician
  • Known allergy to Asteraceae plants (ragweed, chrysanthemum, mugwort, chamomile)
  • Active chemotherapy with a P-glycoprotein substrate, during and for 7 days around each cycle
  • Chronic kidney disease with eGFR below 30 mL/min/1.73 m²
  • Decompensated cirrhosis, Child-Pugh Class C
  • Bowel obstruction or ileus
  • Pregnancy and breastfeeding
    •
Key Interactions
  • Loop and thiazide diuretics (furosemide, hydrochlorothiazide)
  • Glucose-lowering drugs (insulin, metformin, sulfonylureas)
  • Lithium
  • Warfarin
  • CYP3A4 substrates with narrow windows (ciclosporin, tacrolimus)
  • Over-the-counter medications (ibuprofen, aspirin, antacids, potassium supplements)
  • Supplements with additive diuretic effect (juniper, uva-ursi, horsetail)
  • Supplements with additive glucose-lowering effect (berberine, bitter melon)
  • Prolonged fasting, ketogenic eating, sauna or heat protocols
    •

Risk & Side Effects

  • Medium: Allergic reaction in people sensitized to the daisy family; forgone or delayed standard cancer treatment
  • Low: Low blood sugar; increased urination and fluid loss; digestive upset; bile-duct pain and blockage
  • Speculative: Weakening of a standard chemotherapy drug; heavy metal load from the root

Monitoring

Marker Target Why
Potassium 4.0–4.5 mmol/L Diuresis shifts it; the root also supplies potassium
Sodium 138–142 mmol/L Detects dilution or depletion from fluid shifts
eGFR Above 90 mL/min/1.73 m² Sets whether the diuretic load is safe
Fasting glucose 75–86 mg/dL Catches the additive glucose-lowering signal
ALT 10–26 U/L (women), 10–30 U/L (men) Screens for liver strain from a bitter, bile-active herb
CBC Stable against own baseline Tracks blood counts during any concurrent cancer treatment
Blood lead Change from own baseline, below 3.5 µg/dL The taproot accumulates lead from soil

Cadence: Baseline, 2 weeks, 6 weeks, then every 3 months while use continues; extra potassium check after vomiting or diarrhea; blood lead annually.

Qualitative Assessment

  • Appetite and post-meal comfort
  • Night-time urination frequency
  • Lightheadedness on standing
  • Skin and mouth symptoms — itching, rash, tingling lips
  • Energy and exercise tolerance
  • Stool frequency and consistency
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.